✦ LIBER ✦

140 Mortality as an endpoint in OSA

✍ Scribed by Jose M. Marin

Book ID: 116883994
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 67 KB
Volume: 7
Category: Article
ISSN: 1389-9457
DOI: 10.1016/j.sleep.2006.07.044

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mortality as an endpoint in atrial fibri

Mortality as an endpoint in atrial fibrillation1

✍ BEYERBACH, D; ZIPES, D 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Mortality as an endpoint for cardiac fai

Mortality as an endpoint for cardiac failure therapy

✍ Jay N. Cohn 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 981 KB

Should morbidity replace mortality as an

Should morbidity replace mortality as an endpoint for clinical trials in intensive care?

✍ A.J. Petros; J.C. Marshall; H.K.F. van Saene 📂 Article 📅 1995 🏛 The Lancet 🌐 English ⚖ 467 KB

Are there alternatives to mortality as a

Are there alternatives to mortality as an endpoint in clinical trials of atrial fibrillation?

✍ GEORGEWYSE, D 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Morbidity or mortality as endpoint for c

Morbidity or mortality as endpoint for clinical trials in intensive care

✍ Johan Decruyenaere; Cathy De Deyne; Jan Poelaert; Francis Colardyn 📂 Article 📅 1995 🏛 The Lancet 🌐 English ⚖ 537 KB

Tissue autofluorescence as an intermedia

Tissue autofluorescence as an intermediate endpoint in cancer chemoprevention trials

✍ Stimson P. Schantz; Robert R. Alfano 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 583 KB

Intermediate endpoints which reflect responsiveness to chemopreventive agents are needed in clinical trials. A potential problem in the assessment of these endpoints is their requirement for invasive biopsies. Secondly, their expression within the aerodigestive tract is doubtfully uniform. Without c